The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

Donanemab, the most effective treatment yet for the disease, has been banned on the health service despite regulators ...

Tens of thousands of people will be recruited into Alzheimer’s trials after a landmark drug was rejected for use on the NHS.

The drug is a new treatment for Alzheimer's disease. However, the National Institute for Health and Care Excellence (NICE) has not recommended that donanemab is approved for use on the NHS. The ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A couple from Hull have called on the government to fund new Alzheimer's drugs, even though they say it will come "too late" ...

The UK's leading baby charity working to prevent sudden deaths and promote health. Lullaby funds research, supports bereaved families and promotes safe baby care advice, including helpline for ...

A retired journalist who took part in the clinical trial for the new Alzheimer’s drug has described how he feels “as normal ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news ...

A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

Donanemab, given as an infusion every four weeks, has shown to slow down cognitive decline by 4-7 months in clinical studies.